Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Most loved Seared Chicken: Which Chain Rules? - 2Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts
- 3Which Startup's Innovation Could Alter Medical services?
- 46 US States for Fly Fishing
- 5Addressing sleep apnea early might decrease chances of developing Parkinson's disease
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
- Ukrainian foreign minister appeals for funds for drones
- Figure out How to Utilize Your Web based Advertising Degree to Break into the Tech Business
- Top 10 Smash hit Computer games of the Year
- Vote in favor of your Number one natural product
- Top 10 Moving Style Architects of the Year
- Hundreds of Gazans evacuated from Strip for medical treatment - COGAT
- 'The Secret Lives of Mormon Wives' Season 3 premieres tomorrow. Here's what you need to know to catch up.
- What to know about King Charles III's cancer treatment and his message to the public
